Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.
Allen Roses, MD
Fine-mapping and characterization of genetic biomarkers that facilitate the acceleration of drug discovery for frontotemporal dementias
A GuideStar-Rated Charity
© Copyright 2025. The Alzheimer's Drug Discovery Foundation, a not-for-profit, section 501 (c)(3).